• Sekar Subashini Research Scholar, Department of Biotechnology, School of Life Sciences, Vels University, Pallavaram, Chennai-600117
  • Kodukur Viswanathan Pugalendi


Objectives: Diabetes mellitus is associated with profound alterations in the levels of plasma lipids and the lipoprotein profile. Herbs and herbal drug
preparations find wide use in alleviating the complications of uncontrolled diabetes owing to their low cost and lesser side effects. This study was
aimed at establishing the hypolipidemic effect of methanolic extract of sea weed Gracilaria corticata on streptozotocin (STZ)-induced diabetic rats.
Methods: STZ-induced Wistar male albino rats were administered with methanolic extract of Gracilaria corticata (MGC) at a dosage of 100 mg/kg
BW/day per orally for 45 days. Glibenclamide (600 μg/kg BW/day) administered rats served as standard drug control. Animals were sacrificed on
46th day, biochemical parameters associated with lipid metabolism were analyzed in blood and tissue samples, statistical significance determined.
Results: Elevated levels of total cholesterol, triglycerides, and free fatty acids were observed in the plasma and tissues of diabetic rats as compared to
MGC and glibenclamide treated groups. The diabetic rats also had elevated levels of low-density lipoprotein (LDL-C) and very low-density lipoprotein
(VLDL-C) and decreased levels of high-density lipoprotein (HDL-C) while the MGC and glibenclamide treated rats showed near normal levels of these
Conclusion: This study establishes the hypolipidemic potential of MGC in STZ-induced diabetic rats.
Keywords: Gracilaria corticata, Diabetes mellitus, Hypolipidemic, Streptozotocin.

Author Biography





1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2012;30:S42-7.
2. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010;87(1):4-14.
3. Szkudelski T. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res 2001;50(6):537-46.
4. Sushma N, Smitha PV, Gopal YV, Vinay R, Reddy NS, Mohan CM, et al. Antidiabetic, antihyperlipidemic and antioxidant activities of Buchanania lanzan Spreng methanol leaf extract in streptozotocin-induced Types I and II diabetic rats. Trop J Pharm Res 2013;12(2):221-6.
5. Kameswara Rao B, Giri R, Kesavulu MM, Apparao C. Effect of oral administration of bark extracts of Pterocarpus santalinus L. On blood glucose level in experimental animals. J Ethnopharmacol 2001;74(1):69-74.
6. Betteridge DJ. Diabetic dyslipidemia. Am J Med 1994;96(6A):25S-31.
7. Najafi S, Deokule SS. Pharmacognostic study of Tylophora dalzellii Hook. f. J Med Plants Res 2010;4(5):403-6.
8. Eloff JN. Which extractant should be used for the screening and isolation of antimicrobial components from plants? J Ethnopharmacol 1998;60(1):1-8.
9. Namvar F, Mohamad R, Baharara J, Zafar-Balanejad S, Fargahi F, Rahman HS. Antioxidant, antiproliferative, and antiangiogenesis effects of polyphenol-rich seaweed (Sargassum muticum). Biomed Res Int 2013;2013:1-9.
10. Southgate DA, Waldron K, Johnsons IT, Fenwick GR. Dietary Fiber and Health: Chemical Biological Aspects. London: Royal; 1990. p. 10-9.
11. Ribeiro LR, Salvadori DM. Dietary components may prevent mutation-related diseases in humans. Mutat Res 2003;544(2-3):195-201.
12. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem 1974;20(4):470-5.
13. McGowan MW, Artiss JD, Strandbergh DR, Zak B. A peroxidase-coupled method for the colorimetric determination of serum triglycerides. Clin Chem 1983;29(3):538-42.
14. Falholt K, Lund B, Falholt W. An easy colorimetric micromethod for routine determination of free fatty acids in plasma. Clin Chim Acta 1973;46(2):105-11.
15. Zilversmit DB, Davis AK. Microdetermination of plasma phospholipids by trichloroacetic acid precipitation. J Lab Clin Med 1950;35(1):155-60.
16. Izzo C, Grillo F, Murador E. Improved method for the determination of high density lipoprotein cholesterol, I. Isolation of high-density lipoproteins by the use of polyethylene glycol 6000. Clin Chem 1981;27(3):371-4.
17. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18(6):499-502.
18. Fontbonne A, Eschwège E, Cambien F, Richard JL, Ducimetière P, Thibult N, et al. Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study. Diabetologia 1989;32(5):300-4.
19. Motta M, Giugno I, Bosco S, Pistone G, Ruello P, Maugeri D, et al. Serum lipoprotein(a) changes in acute myocardial infarction. Panminerva Med 2001;43(2):77-80.
20. Nesto RW. Beyond low-density lipoprotein: Addressing the atherogenic lipid triad in Type 2 diabetes mellitus and the metabolic syndrome. Am J Cardiovasc Drugs 2005;5(6):379-87.
21. Blevins T. Therapeutic options that provide glycemic control and weight loss for patients with Type 2 diabetes. Postgrad Med 2010;122(1):172-83.
22. Marinangeli CP, Varady KA, Jones PJ. Plant sterols combined with exercise for the treatment of hypercholesterolemia: Overview of independent and synergistic mechanisms of action. J Nutr Biochem 2006;17(4):217-24.
23. Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, Howard BV, et al. Diabetes and cardiovascular disease: A statement for healthcare professionals from the American Heart Association. Circulation 1999;100(10):1134-46.
24. Peter MA, Kathleen BM. Cholesterol synthesis, transport and excretion. In: Murray RK, Bender DA, Botham KM, Kennelly PJ, Rodwell VW, Anthony WP, editors. Harper’s Illustrated Biochemistry. 28th ed. Lange: McGraw-Hill; 2009.
25. Oladele SB, Ayo JO, Adaudi AO. Medicinal and physiological properties of flavonoids, coumarin derivatives and anthraquinones of plant origin. West Afr J Pharmacol Drug Res 1995;11:134-44.
26. Dhande SR, Kaikini AA, Patil KA, Kadam V. Antihyperlipidemic activity of Bambusa Bambos (Druce.) And Swertia chirata (Buch-Ham) in cholesterol suspension induced hypercholesterolemia in rats. Int J Pharm Pharm Sci 2014;6(1):607-10.
27. Mustaffa F, Hassan Z, Yusof NA, Razak KN, Asmawi MZ. Antidiabetic and antihyperlipidemic potential of standardized extract, fraction and subfraction of Cinnamomum iners leaves. Int J Pharm Pharm Sci 2014;6(1):220-5.
28. Topping DL, Storer GB, Calvert GD, Illman RJ, Oakenfull DG, Weller RA. Effects of dietary saponins on fecal bile acids and neutral sterols, plasma lipids and lipoprotein turnover in the pig. Am J Clin Nutr 1980;33(4):783-6.
29. Kritchevsky D. Dietary fiber and other dietary factors in hypercholesterema. Am J Clin Nutr 1977;30(6):979-84.
30. Potter JD, Topping DL, Oakenfull D. Soya, saponins, and plasma-cholesterol. Lancet 1979;1(8109):223.
31. Chanda S, Dave R, Kaneria M, Nagani K. Seaweeds: A novel, untapped source of drugs from sea to combat infectious diseases. Current Research, Technology and Education Topics in Applied. Microbial Biotechnology. Badajoz, Spain: Formatex Research Center; 2010. p. 473-80.
32. Rajasulochana P, Dhamotharan R, Krishnamoorthy P, Murugesan S. Antibacterial activity of the extracts of marine red and brown algae. J Am Sci 2009;5(3):20-5.
33. Jeeva S, Antonisamy MJ, Domettila C, Anantham B, Mahesh M. Preliminary phytochemical studies on some selected seaweeds from Gulf of Mannar, India. Asian Pac J Trop Biomed 2012;S30-3.
34. Cofrades S, López-López I, Bravo L, Ruiz-Capillas C, Bastida S, Larrea MT, et al. Nutritional and antioxidant properties of different brown and red Spanish edible seaweeds. Food Sci Technol Int 2010;16(5):361-70.
35. Matanjun P, Mohamed S, Muhammad K, Mustapha NM. Comparison of cardiovascular protective effects of tropical seaweeds, Kappaphycus alvarezii, Caulerpa lentillifera, and Sargassum polycystum, on high-cholesterol/high-fat diet in rats. J Med Food 2010;13(4):792-800.
36. Subashini S, Pugalendi KV, Baskaran K, Kripa KG. Anti-hyperglycaemic effect of Gracilaria corticata extracts on STZ-induced diabetic rats. Chem Biol Lett 2015;2(1):6-11.
37. Arvind K, Pradeepa R, Deepa R, Mohan V. Diabetes & coronary artery disease. Indian J Med Res 2002;116:163-76.
38. Shepherd J. Does statin monotherapy address the multiple lipid abnormalities in Type 2 diabetes? Atheroscler Suppl 2005;6(3):15-9.
39. Shirwaikar A, Rajendran K, Barik R. Effect of aqueous bark extract of Garuga pinnata Roxb. In streptozotocin-nicotinamide induced Type-II diabetes mellitus. J Ethnopharmacol 2006;107(2):285-90.
400 Views | 339 Downloads
How to Cite
Subashini, S., K. G. Kripa, and K. V. Pugalendi. “HYPOLIPIDEMIC POTENTIAL OF METHANOLIC EXTRACT OF GRACILARIA CORTICATA ON STREPTOZOTOCIN-INDUCED DIABETIC RATS”. Asian Journal of Pharmaceutical and Clinical Research, Vol. 10, no. 3, Mar. 2017, pp. 402-5, doi:10.22159/ajpcr.2017.v10i3.16373.
Original Article(s)